外体PKM2:一种非侵入性诊断标记,将巨细胞代谢重编程与胃癌发病因子联系起来

Mengyun Yuan1, Xiaoxia Zheng2, Shanshan Zheng2

  • 1Department of Oncology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.

Cancer science
|March 24, 2025
PubMed
概括

血外体酸激酶异酶类型M2 (PKM2) 显示为早期胃癌 (GC) 诊断和预测不良预后的生物标志物具有前途. 它还通过激活瘤相关巨细胞中的脂质合成来促进GC进展.